Atai Life Sciences Investing Activities - Other 2020-2025 | ATAI

Atai Life Sciences investing activities - other from 2020 to 2025. Investing activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the investing activities section of the Cash Flows Statement
Atai Life Sciences Annual Investing Activities - Other
(Millions of US $)
2024 $59
2023 $-53
2022 $-86
2021 $-27
2020 $-26
2019 $-9
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.411B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.898B 19.61
Encompass Health (EHC) United States $12.270B 26.01
DaVita (DVA) United States $11.006B 15.48
Chemed (CHE) United States $8.507B 26.74
Elanco Animal Health (ELAN) United States $6.496B 13.91
Option Care Health (OPCH) United States $5.415B 24.14
RadNet (RDNT) United States $4.514B 286.48
Amedisys (AMED) United States $3.109B 20.91
LifeStance Health (LFST) United States $2.267B 0.00
Addus HomeCare (ADUS) United States $2.070B 22.73
Astrana Health (ASTH) United States $1.518B 37.61
U.S Physical Therapy (USPH) United States $1.206B 31.14
Aveanna Healthcare Holdings (AVAH) United States $1.122B 63.89
Pennant (PNTG) United States $1.014B 37.25
MEDIROM Healthcare Technologies (MRM) Japan $0.037B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00